FindTrial
Sign In

Intense Pulsed Light Treatment for Dry Eye Disease due to Meibomian Gland Function

Intense Pulsed Light Treatment for Dry Eye Disease due to Meibomian Gland Function in Skin Type III-IV

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17010867
Enrollment
Unknown
Registered
2017-03-14
Start date
2017-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Disease due to Meibomian Gland Function

Interventions

Four:IPL(Intense Pulsed Light) treatmnet

Sponsors

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Screening patients with skin type III-IV and moderate or severe MGD in both eyes for several years who had no improvement after traditional treatment, age 18 or older.

Exclusion criteria

Exclusion criteria: Individuals should be excluded with the following situation: taking part in other clinical trials, infection in the face area, with chloasma or other skin pigmentary lesions, take photosensitizer recently, the pregnancy.

Design outcomes

Primary

MeasureTime frame
Tear Film Break up Time;—

Secondary

MeasureTime frame
Fluorescein Staining of Corneal;Schirmer's Test;—

Countries

China

Contacts

Public ContactLi Dan

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong

13729262500@139.com+86 13729262500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026